Nina Wagner-Johnston

Associate Professor


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nina Wagner-Johnston is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner-Johnston, N., Dwyer, M. A. & Sundar, H., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

  • Correction: First-in-human phase 1 study of the BTK inhibitor GDC-0853 in relapsed or refractory B-cell NHL and CLL (Oncotarget(2018) 9 (13023 -13035) DOI: 10.18632/oncotarget.24310)

    Byrd, J. C., Smith, S., Wagner-Johnston, N., Sharman, J., Chen, A. I., Advani, R., Augustson, B., Marlton, P., Renee Commerford, S., Okrah, K., Liu, L., Murray, E., Penuel, E., Ward, A. F. & Flinn, I. W., Jan 1 2019, In : Oncotarget. 10, 38, p. 3827-3830 4 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: Clinical outcomes of the Phase III intergroup trial alliance/CALGB 50303

    Bartlett, N. L., Wilson, W. H., Jung, S. H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M. Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., Friedberg, J. W., Staudt, L. M., Wagner-Johnston, N. D., Blum, K. A., Abramson, J. S., Reddy, N. M., Winter, J. N., Chang, J. E., Gopal, A. K., Chadburn, A. & 6 others, Mathew, S., Fisher, R. I., Richards, K. L., Schoder, H., Zelenetz, A. D. & Leonard, J. P., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1790-1799 10 p.

    Research output: Contribution to journalArticle

  • DYNAMO: A Phase II study of duvelisib (IPI-145) in patients with refractory indolent non-hodgkin lymphoma

    Flinn, I. W., Miller, C. B., Ardeshna, K. M., Tetreault, S., Assouline, S. E., Mayer, J., Merli, M., Lunin, S. D., Pettitt, A. R., Nagy, Z., Tournilhac, O., Abou-Nassar, K. E., Crump, M., Jacobsen, E. D., De Vos, S., Kelly, V. M., Shi, W., Steelman, L., Le, N. D., Weaver, D. T. & 3 others, Lustgarten, S., Wagner-Johnston, N. & Zinzani, P. L., Jan 1 2019, In : Journal of Clinical Oncology. 37, 11, p. 912-922 11 p.

    Research output: Contribution to journalArticle

    Open Access